Understanding how Tet1 influences the development of myofibroblasts
The role of Tet1 in myofibroblast differentiation
This study is looking at how a protein called Tet1 helps certain cells, known as myofibroblasts, grow and function, which is important for healing and understanding diseases like cancer, so that patients can gain better insights into how these cells work in their bodies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10812997 on NIH RePORTER |
What this research studies
This research investigates the role of Tet1, a protein involved in DNA modification, in the differentiation of myofibroblasts, which are important cells in tissue repair and cancer. The study focuses on how Tet1 affects the expression of specific genes related to myofibroblast development through mechanisms like DNA methylation. By examining the differences in gene regulation between myofibroblasts and other cell types, the research aims to uncover new insights into how these cells contribute to various diseases. Patients may benefit from a better understanding of myofibroblast behavior in conditions like cancer and tissue repair.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions involving abnormal myofibroblast activity, such as certain cancers or fibrotic diseases.
Not a fit: Patients with conditions unrelated to myofibroblast differentiation or those not experiencing tissue repair issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies targeting myofibroblast differentiation in cancer and tissue repair.
How similar studies have performed: Previous studies have shown the importance of epigenetic factors in cell differentiation, suggesting that this research could build on established findings.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Liu, Tianju — University of Michigan at Ann Arbor
- Study coordinator: Liu, Tianju
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.